Новости | Магазин | Журналы | Контакты | Правила | Доставка | |
Вход Регистрация |
Цель. Анализ актуальных методов оценки качества жизни пациентов, проходящих хирургическое лечение по поводу рака поджелудочной железы и периампулярной зоны, изучение влияния хирургического лечения и послеоперационных осложнений на качество жизни. Материал и методы. Проведен систематический обзор литературы, содержащейся в электронных базах данных MEDLINE, Embase и e-Library, за 2015–2022 гг. Методология систематического обзора отражена в протоколе исследования, составленного в соответствии с рекомендациями PRISMA. Результаты. В систематический обзор вошли 26 исследований, включавших 4937 пациентов, отвечающих критериям включения. Были изучены такие характеристики исследований, как дизайн и задачи, опросные формы, методы хирургического и лекарственного лечения, периодичность опроса и методика сбора данных, риск систематической ошибки и др. Заключение. При выборе опросной формы большинство авторов отдавали предпочтение EORTC QLQ-C30 и EORTC QLQ-PAN26. Даже наиболее сложные операции, такие как панкреатодуоденальная резекция и панкреатэктомия, позволяют добиться удовлетворительного качества жизни. Во многих актуальных исследованиях присутствуют методологические недостатки, увеличивающие риск систематической ошибки и уменьшающие достоверность полученных данных. Необходимо дальнейшее изучение качества жизни пациентов этой категории, стандартизация оптимальных принципов и методологии проведения подобных исследований, в частности, в отечественном здравоохранении.
Ключевые слова:
поджелудочная железа, периампулярная зона, качество жизни, злокачественные новообразования, опросная форма, хирургическое лечение, pancreas, periampullary area, quality of life, malignant neoplasms, survey form, surgical treatment
Литература:
1.Khalaf N., El-Serag H.B., Abrams H.R., Thrift A.P. Burden of pancreatic cancer: from epidemiology to practice. Clin. Gastroenterol. Hepatol. 2021; 19 (5): 876–884. doi: 10.1016/j.cgh.2020.02.054
2.Li J., Li Y., Chen C., Guo J., Qiao M., Lyu J. Recent estimates and predictions of 5-year survival rate in patients with pancreatic cancer: a model-based period analysis. Front. Med. (Lausanne). 2022; 9: 1049136. doi: 10.3389/fmed.2022.1049136
3.Beesley V.L., Wockner L.F., O'Rourke P., Janda M., Goldstein D., Gooden H., Merrett N.D., O'Connell D.L., Rowlands I.J., Wyld D.K., Neale R.E. Risk factors for current and future unmet supportive care needs of people with pancreatic cancer. A longitudinal study [published correction appears in Support Care Cancer. 2016; 24 (8): 3601–3602. Support Care Cancer. 2016; 24 (8): 3589–3599. doi: 10.1007/s00520-016-3212-4
4.Heerkens H.D., Tseng D.S., Lips I.M., van Santvoort H.C., Vriens M.R., Hagendoorn J., Meijer G.J., Borel Rinkes I.H., van Vulpen M., Molenaar I.Q. Health-related quality of life after pancreatic resection for malignancy. Br. J. Surg. 2016; 103 (3): 257–266. doi: 10.1002/bjs.10032
5.Eaton A.A., Gonen M., Karanicolas P., Jarnagin W.R., D'Angelica M.I., DeMatteo R., Kingham T.P., Allen P.J. Health-related quality of life after pancreatectomy: results from a randomized controlled trial. Ann. Surg. Oncol. 2016; 23 (7): 2137–2145. doi: 10.1245/s10434-015-5077-z
6.Arvaniti M., Danias N., Theodosopoulou E., Smyrniotis V., Karaoglou M., Sarafis P. Quality of life variables assessment, before and after pancreatoduodenectomy (PD): prospective study. Glob. J. Health Sci. 2015; 8 (6): 203–210. doi: 10.5539/gjhs.v8n6p203
7.Hartwig W., Gluth A., Hinz U., Bergmann F., Spronk P.E., Hackert T., Werner J., Buchler M.W. Total pancreatectomy for primary pancreatic neoplasms: renaissance of an unpopular operation. Ann. Surg. 2015; 261 (3): 537–546. doi: 10.1097/SLA.0000000000000791
8.Watanabe Y., Ohtsuka T., Matsunaga T., Kimura H., Tamura K., Ideno N., Aso T., Miyasaka Y., Ueda J., Takahata S., Igarashi H., Inoguchi T., Ito T., Tanaka M. Long-term outcomes after total pancreatectomy: special reference to survivors' living conditions and quality of life. World J. Surg. 2015; 39 (5): 1231–1239. doi: 10.1007/s00268-015-2948-1
9.Wu W., Dodson R., Makary M.A., Weiss M.J., Hirose K., Cameron J.L., Ahuja N., Pawlik T.M., Wolfgang C.L., He J. A Contemporary evaluation of the cause of death and long-term quality of life after total pancreatectomy. World J. Surg. 2016; 40 (10): 2513–2518. doi: 10.1007/s00268-016-3552-8
10.Casadei R., Ricci C., Taffurelli G., Guariniello A., Di Gioia A., Di Marco M., Pagano N., Serra C., Calculli L., Santini D., Minni F. Is total pancreatectomy as feasible, safe, efficacious, and cost-effective as pancreaticoduodenectomy? A single center, prospective, observational study. J. Gastrointest. Surg. 2016; 20 (9): 1595–1607. doi: 10.1007/s11605-016-3201-4
11.Heerkens H.D., van Berkel L., Tseng D.S.J., Monninkhof E.M., van Santvoort H.C., Hagendoorn J., Borel Rinkes I.H.M., Lips I.M., Intven M., Molenaar I.Q. Long-term health-related quality of life after pancreatic resection for malignancy in patients with and without severe postoperative complications. HPB (Oxford). 2018; 20 (2): 188–195. doi: 10.1016/j.hpb.2017.09.003
12.Fong Z.V., Alvino D.M., Castillo C.F., Nipp R.D., Traeger L.N., Ruddy M., Lubitz C.C., Johnson C.D., Chang D.C., Warshaw A.L., Lillemoe K.D., Ferrone C.R. Health-related quality of life and functional outcomes in 5-year survivors after pancreaticoduodenectomy. Ann. Surg. 2017; 266 (4): 685–692. doi: 10.1097/SLA.0000000000002380
13.Zhang R.C., Zhang B., Mou Y.P., Xu X.W., Zhou Y.C., Huang C.J., Zhou J.Y., Jin W.W., Lu C. Comparison of clinical outcomes and quality of life between laparoscopic and open central pancreatectomy with pancreaticojejunostomy. Surg. Endosc. 2017; 31 (11): 4756–4763. doi: 10.1007/s00464-017-5552-7
14.Laitinen I., Sand J., Peromaa P., Nordback I., Laukkarinen J. Quality of life in patients with pancreatic ductal adenocarcinoma undergoing pancreaticoduodenectomy. Pancreatology. 2017; 17 (3): 445–450. doi: 10.1016/j.pan.2017.02.013
15.Baekelandt B.M.G., Fagerland M.W., Hjermstad M.J., Heiberg T., Labori K.J., Buanes T.A. Survival, complications and patient reported outcomes after pancreatic surgery. HPB (Oxford). 2019; 21 (3): 275–282. doi: 10.1016/j.hpb.2018.07.023
16.Klaiber U., Probst P., Huttner F.J., Bruckner T., Strobel O., Diener M.K., Mihaljevic A.L., Buchler M.W., Hackert T. Randomized trial of pylorus-preserving vs. pylorus-resecting pancreatoduodenectomy: long-term morbidity and quality of life. J. Gastrointest. Surg. 2020; 24 (2): 341–352. doi: 10.1007/s11605-018-04102-y
17.Arvaniti M., Danias N., Igoumenidis M., Smyrniotis V., Tsounis A., Sarafis P. Comparison of quality of life before and after pancreaticoduodenectomy: a prospective study. Electron Physician. 2018; 10 (7): 7054–7062. doi: 10.19082/7054
18.Alfieri S., Agnes A., Rosa F., Di Miceli D., Grieco D.L., Scaldaferri F., Gasbarrini A., Doglietto G.B., Quero G. Long-term pancreatic exocrine and endometabolic functionality after pancreaticoduodenectomy. Comparison between pancreaticojejunostomy and pancreatic duct occlusion with fibrin glue. Eur. Rev. Med. Pharmacol. Sci. 2018; 22 (13): 4310–4318. doi: 10.26355/eurrev_201807_15427
19.Scholten L., Latenstein A.E.J., van Eijck C., Erdmann J., van der Harst E., Mieog J.S.D., Molenaar I.Q., van Santvoort H.C., DeVries J.H., Besselink M.G., Dutch Pancreatic Cancer Group. Outcome and long-term quality of life after total pancreatectomy (PANORAMA): a nationwide cohort study. Surgery. 2019; 166 (6): 1017–1026. doi: 10.1016/j.surg.2019.07.025
20.Overbeek K.A., Cahen D.L., Kamps A., Konings I.C.A.W., Harinck F., Kuenen M.A., Koerkamp B.G., Besselink M.G., van Eijck C.H., Wagner A., Ausems M.G.E., van der Vlugt M., Fockens P., Vleggaar F.P., Poley J.W., van Hooft J.E., Bleiker E.M.A., Bruno M.J.; Dutch Familial Pancreatic Cancer Surveillance Study Group. Patient-reported burden of intensified surveillance and surgery in high-risk individuals under pancreatic cancer surveillance. Fam. Cancer. 2020; 19 (3): 247–258. doi: 10.1007/s10689-020-00171-8
21.Nakashima Y., Kawae T., Iwaki D., Fudeyasu K., Kimura H., Uemura K., Okamura H. Changes in motor function and quality of life after surgery in patients with pancreatic cancer. Eur. J. Cancer Care (Engl.). 2021; 30 (2): e13368. doi: 10.1111/ecc.13368
22.Mackay T.M., Latenstein A.E.J., Sprangers M.A.G., van der Geest L.G., Creemers G.J., van Dieren S., de Groot J.B., Groot Koerkamp B., de Hingh I.H., Homs M.Y.V., de Jong E.J.M., Molenaar I.Q., Patijn G.A., van de Poll-Franse L.V., van Santvoort H.C., de Vos-Geelen J., Wilmink J.W., van Eijck C.H., Besselink M.G., van Laarhoven H.W.M.; Dutch Pancreatic Cancer Group. Relationship between quality of life and survival in patients with pancreatic and periampullary cancer: a multicenter cohort analysis. J. Natl. Compr. Canc. Netw. 2020; 18 (10): 1354–1363. doi: 10.6004/jnccn.2020.7579
23.Mackay T.M., van Rijssen L.B., Andriessen J.O., Suker M., Creemers G.J., Eskens F.A., de Hingh I.H., van de Poll-Franse L.V., Sprangers M.A.G., Busch O.R., Wilmink J.W., van Eijck C.H., Besselink M.G., van Laarhoven H.W.; Dutch Pancreatic Cancer Group. Patient satisfaction and quality of life before and after treatment of pancreatic and periampullary cancer: a prospective multicenter study. J. Natl. Compr. Canc. Netw. 2020; 18 (6): 704–711. doi: 10.6004/jnccn.2020.7528
24.Oh M.Y., Kim E.J., Kim H., Byun Y., Han Y., Choi Y.J., Kang J.S., Kwon W., Jang J.Y. Changes in postoperative long-term nutritional status and quality of life after total pancreatectomy. Ann. Surg. Treat. Res. 2021; 100 (4): 200–208. doi: 10.4174/astr.2021.100.4.200
25.De Pastena M., Esposito A., Paiella S., Surci N., Montagnini G., Marchegiani G., Malleo G., Secchettin E., Casetti L., Ricci C., Landoni L., Bovo C., Bassi C., Salvia R. Cost-effectiveness and quality of life analysis of laparoscopic and robotic distal pancreatectomy: a propensity score-matched study. Surg. Endosc. 2021; 35 (3): 1420–1428. doi: 10.1007/s00464-020-07528-1
26.Korrel M., Roelofs A., van Hilst J., Busch O.R., Daams F., Festen S., Groot Koerkamp B., Klaase J., Luyer M.D., van Oijen M.G., Verdonck-de Leeuw I.M., Besselink M.G.; LEOPARD Trial Collaborators. Long-Term Quality of Life after Minimally Invasive vs Open Distal Pancreatectomy in the LEOPARD Randomized Trial. J. Am. Coll. Surg. 2021; 233 (6): 730–739.e9. doi: 10.1016/j.jamcollsurg.2021.08.687
27.Mackay T.M., Dijksterhuis W.P.M., Latenstein A.E.J., van der Geest L.G., Sprangers M.A.G., van Eijck C.H.J., Homs M.Y.V., Luelmo S.A.C., Molenaar I.Q., van Santvoort H., Schreinemakers J.M.J., Wilmink J.W., Besselink M.G., van Laarhoven H.W., van Oijen M.G.H.; Dutch Pancreatic Cancer Group. The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis. HPB (Oxford). 2022; 24 (4): 443–451. doi: 10.1016/j.hpb.2021.09.003
28.Marchegiani G., Perri G., Burelli A., Zoccatelli F., Andrianello S., Luchini C., Donadello K., Bassi C., Salvia R. High-risk pancreatic anastomosis versus total pancreatectomy after pancreatoduodenectomy: postoperative outcomes and quality of life analysis. Ann. Surg. 2022; 276 (6): e905–e913. doi: 10.1097/SLA.0000000000004840
29.Stoop T.F., Ghorbani P., Scholten L., Bergquist E., Ateeb Z., van Dieren S., Holmberg M., Besselink M.G., Sparrelid E., Del Chiaro M. Total pancreatectomy as an alternative to high-risk pancreatojejunostomy after pancreatoduodenectomy: a propensity score analysis on surgical outcome and quality of life. HPB (Oxford). 2022; 24 (8): 1261–1270. doi: 10.1016/j.hpb.2021.12.018
30.Maharaj A.D., Samoborec S., Evans S.M., Zalcberg J., Neale R.E., Goldstein D., Merrett N., White K., Croagh D., Pilgrim C.H.C., Evans P., Knowles B., Leong T., Philip J., Smith M., Ioannou L. Patient-reported outcome measures (PROMs) in pancreatic cancer : a systematic review. HPB (Oxford). 2020; 22 (2): 187–203. doi: 10.1016/j.hpb.2019.09.002
31.Groenvold M., Klee M.C., Sprangers M.A., Aaronson N.K. Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient-observer agreement. J. Clin. Epidemiol. 1997; 50 (4): 441–450. doi: 10.1016/s0895-4356(96)00428-3
32.Eaton A.A., Karanicolas P., Johnson C.D., Bottomley M.A., Allen P.J., Gonen M. Psychometric validation of the EORTC QLQ-PAN26 pancreatic cancer module for assessing health related quality of life after pancreatic resection. JOP. J. Pancreas (Online). 2017; 18 (1): 19–25.
Aim. To analyze the current methods of life quality assessment in patients undergoing surgical treatment for pancreatic and periampullary cancer, to study the influence of surgical treatment and postoperative complications on the quality of life. Materials and methods. The study involves a systematic review of the literature available in MEDLINE, Embase and e-Library electronic databases for 2015–2022. The methodology of the systematic review is reflected in the study protocol, designed according to PRISMA guidelines. Results. The systematic review embraces 26 studies including 4937 patients met the inclusion criteria. The present study examines design and objectives, survey forms, methods of surgical interventions and drug treatment, survey frequency and data collection methodology, risk of systematic error, etc. Conclusion. When choosing a survey form, most authors favored EORTC QLQ-C30 and EORTC QLQ-PAN26. Even the most complex surgeries such as pancreaticoduodenal resection and pancreatectomy can provide a satisfactory quality of life. Many current studies appear methodologically-challenged thereby increasing the risk of systematic error and reducing the reliability of the data. The quality of life of patients in this category is to be further investigated, the optimal principles and methodology of such studies are to be standardized, in particular, in Russian healthcare system.
Keywords:
поджелудочная железа, периампулярная зона, качество жизни, злокачественные новообразования, опросная форма, хирургическое лечение, pancreas, periampullary area, quality of life, malignant neoplasms, survey form, surgical treatment